Profile | GDS5420 / 218013_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 296.58 | 58 |
GSM1296119 | B_lesional_pre-dose | 743.06 | 75 |
GSM1296076 | C_lesional_pre-dose | 666.22 | 73 |
GSM1296092 | D_lesional_pre-dose | 681.89 | 73 |
GSM1296103 | E_lesional_pre-dose | 211.3 | 53 |
GSM1296078 | F_lesional_pre-dose | 739.78 | 75 |
GSM1296107 | G_lesional_pre-dose | 679.03 | 73 |
GSM1296109 | H_lesional_pre-dose | 323.1 | 59 |
GSM1296080 | I_lesional_pre-dose | 264.3 | 58 |
GSM1296090 | J_lesional_pre-dose | 662.43 | 73 |
GSM1296074 | K_lesional_pre-dose | 707.06 | 74 |
GSM1296111 | L_lesional_pre-dose | 824.21 | 76 |
GSM1296099 | M_lesional_pre-dose | 355.38 | 61 |
GSM1296086 | O_lesional_pre-dose | 528.46 | 69 |
GSM1296117 | P_lesional_pre-dose | 757.1 | 75 |
GSM1296113 | Q_lesional_pre-dose | 699.36 | 73 |
GSM1296096 | R_lesional_pre-dose | 276.53 | 58 |
GSM1296105 | S_lesional_pre-dose | 305.28 | 59 |
GSM1296098 | T_lesional_pre-dose | 165.94 | 49 |
GSM1296101 | U_lesional_pre-dose | 187.39 | 51 |
GSM1296121 | V_lesional_pre-dose | 671.39 | 73 |
GSM1296088 | W_lesional_pre-dose | 393.67 | 64 |
GSM1296082 | X_lesional_pre-dose | 703.66 | 74 |
GSM1296115 | Y_lesional_pre-dose | 776.59 | 75 |
GSM1296084 | Z_lesional_pre-dose | 255.39 | 57 |
GSM1296072 | B_lesional_day8 | 594.15 | 71 |
GSM1296069 | L_lesional_day8 | 723.58 | 74 |
GSM1296071 | P_lesional_day8 | 486.43 | 66 |
GSM1296070 | Y_lesional_day8 | 690.87 | 73 |
GSM1296073 | V_lesional_day8 | 747.6 | 75 |
GSM1296034 | A_lesional_day15 | 110.71 | 42 |
GSM1296041 | G_lesional_day15 | 826.01 | 76 |
GSM1296035 | R_lesional_day15 | 259.02 | 57 |
GSM1296038 | U_lesional_day15 | 314.73 | 60 |
GSM1296047 | B_lesional_day15 | 543.6 | 69 |
GSM1296039 | E_lesional_day15 | 572.82 | 70 |
GSM1296042 | H_lesional_day15 | 596.37 | 71 |
GSM1296043 | L_lesional_day15 | 575.56 | 70 |
GSM1296037 | M_lesional_day15 | 179.33 | 50 |
GSM1296046 | P_lesional_day15 | 645.15 | 72 |
GSM1296044 | Q_lesional_day15 | 587.61 | 70 |
GSM1296045 | Y_lesional_day15 | 660.76 | 72 |
GSM1296025 | C_lesional_day15 | 210.83 | 54 |
GSM1296033 | D_lesional_day15 | 280.45 | 58 |
GSM1296027 | I_lesional_day15 | 214.72 | 55 |
GSM1296032 | J_lesional_day15 | 281.51 | 58 |
GSM1296024 | K_lesional_day15 | 200.66 | 53 |
GSM1296031 | W_lesional_day15 | 227.37 | 54 |
GSM1296028 | X_lesional_day15 | 322.88 | 60 |
GSM1296029 | Z_lesional_day15 | 119.18 | 44 |
GSM1296026 | F_lesional_day15 | 282.49 | 59 |
GSM1296030 | O_lesional_day15 | 268.35 | 58 |
GSM1296040 | S_lesional_day15 | 187.96 | 51 |
GSM1296036 | T_lesional_day15 | 219.52 | 53 |
GSM1296048 | V_lesional_day15 | 649.11 | 72 |
GSM1296059 | A_lesional_day43 | 208.51 | 54 |
GSM1296066 | G_lesional_day43 | 721.72 | 74 |
GSM1296060 | R_lesional_day43 | 334.98 | 61 |
GSM1296063 | U_lesional_day43 | 505.74 | 68 |
GSM1296064 | E_lesional_day43 | 621.34 | 72 |
GSM1296067 | H_lesional_day43 | 298.17 | 58 |
GSM1296062 | M_lesional_day43 | 188.97 | 51 |
GSM1296068 | Q_lesional_day43 | 597.59 | 70 |
GSM1296050 | C_lesional_day43 | 456.89 | 67 |
GSM1296057 | D_lesional_day43 | 376.18 | 62 |
GSM1296052 | I_lesional_day43 | 178.7 | 52 |
GSM1296054 | J_lesional_day43 | 265.55 | 56 |
GSM1296049 | K_lesional_day43 | 263.51 | 57 |
GSM1296055 | W_lesional_day43 | 381.73 | 63 |
GSM1296053 | X_lesional_day43 | 235.59 | 55 |
GSM1296058 | Z_lesional_day43 | 139.89 | 47 |
GSM1296051 | F_lesional_day43 | 497.93 | 68 |
GSM1296056 | O_lesional_day43 | 307.55 | 60 |
GSM1296065 | S_lesional_day43 | 429.27 | 65 |
GSM1296061 | T_lesional_day43 | 274.07 | 57 |
GSM1296095 | A_non-lesional_pre-dose | 356.12 | 62 |
GSM1296120 | B_non-lesional_pre-dose | 604.14 | 71 |
GSM1296077 | C_non-lesional_pre-dose | 248.77 | 56 |
GSM1296093 | D_non-lesional_pre-dose | 210.43 | 52 |
GSM1296104 | E_non-lesional_pre-dose | 382.42 | 63 |
GSM1296079 | F_non-lesional_pre-dose | 315.98 | 61 |
GSM1296108 | G_non-lesional_pre-dose | 567.97 | 70 |
GSM1296110 | H_non-lesional_pre-dose | 360.93 | 61 |
GSM1296081 | I_non-lesional_pre-dose | 118.3 | 45 |
GSM1296091 | J_non-lesional_pre-dose | 545.08 | 69 |
GSM1296075 | K_non-lesional_pre-dose | 454.72 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 571.67 | 69 |
GSM1296100 | M_non-lesional_pre-dose | 193.79 | 51 |
GSM1296087 | O_non-lesional_pre-dose | 202.5 | 54 |
GSM1296118 | P_non-lesional_pre-dose | 548.2 | 69 |
GSM1296114 | Q_non-lesional_pre-dose | 606.39 | 71 |
GSM1296097 | R_non-lesional_pre-dose | 399.68 | 64 |
GSM1296106 | S_non-lesional_pre-dose | 307.38 | 59 |
GSM1296102 | U_non-lesional_pre-dose | 263.7 | 56 |
GSM1296122 | V_non-lesional_pre-dose | 366.28 | 62 |
GSM1296089 | W_non-lesional_pre-dose | 256.84 | 56 |
GSM1296083 | X_non-lesional_pre-dose | 174.79 | 50 |
GSM1296116 | Y_non-lesional_pre-dose | 598.51 | 70 |
GSM1296085 | Z_non-lesional_pre-dose | 195.48 | 52 |